SCHEMBL22431364

SCHEMBL22431364

CC(=O)NCCSC(=O)CCCCCCCN

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PAOX Q6QHF9 4/20 0.61
TSHR P16473 2/20 0.47
ZDHHC7 Q9NXF8 1/20 0.47
ADRA1A P35348 1/20 0.46
ALDH1A1 P00352 2/20 0.46
KDM4E B2RXH2 1/20 0.45
MAPK1 P28482 1/20 0.45
HIF1A Q16665 1/20 0.45
MTNR1A P48039 4/20 0.40
MTNR1B P49286 4/20 0.40
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.39
PLG P00747 1/20 0.39
LMNA P02545 1/20 0.39
THRB P10828 1/20 0.39
ALOX15 P16050 1/20 0.39
SLC6A2 P23975 1/20 0.39
RECQL P46063 1/20 0.39
SLC6A3 Q01959 1/20 0.39
SLC6A5 Q9Y345 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5088794 0.84 ZDHHC7 (0.59) PAOXTSHRZDHHC7ADRA1AALDH1A1
SCHEMBL23922522 0.83 TSHR (0.60) PAOXTSHRZDHHC7ADRA1AALDH1A1
SCHEMBL15241525 0.80 ZDHHC7 (0.54) PAOXTSHRZDHHC7ADRA1AALDH1A1
SCHEMBL26034291 0.80 TSHR (0.44) PAOXTSHRZDHHC7ADRA1AALDH1A1
SCHEMBL16260817 0.78 TSHR (0.54) PAOXTSHRZDHHC7ADRA1AALDH1A1
SCHEMBL12006469 0.77 PAOX (1.00) PAOXTSHRADRA1AALDH1A1KDM4E
SCHEMBL1409002 0.77 PAOX (1.00) PAOXTSHRADRA1AALDH1A1KDM4E
SCHEMBL21842271 0.77 PAOX (1.00) PAOXTSHRADRA1AALDH1A1KDM4E
SCHEMBL18734790 0.77 TSHR (0.62) PAOXTSHRZDHHC7ADRA1AALDH1A1
SCHEMBL1409041 0.77 PAOX (1.00) PAOXTSHRADRA1AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11739122-B2 Glycopeptide antibiotic compounds, methods for producing the same, and uses thereof ACADEMIA SINICA (TW) 2023-08-29 US disclosed
US-11739122-B2 Glycopeptide antibiotic compounds, methods for producing the same, and uses thereof ACADEMIA SINICA (TW) 2023-08-29 US disclosed
US-20200291071-A1 GLYCOPEPTIDE COMPOUNDS, METHODS FOR PRODUCING THE SAME, AND USES THEREOF ACADEMIA SINICA (TW) 2020-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200291071-A1 GLYCOPEPTIDE COMPOUNDS, METHODS FOR PRODUCING THE SAME, AND USES THEREOF B3GAT3, MGAM, GALNT14 PAOX 2239/4885TSHR 3575/4885ZDHHC7 3016/4885
US-11739122-B2 Glycopeptide antibiotic compounds, methods for producing the same, and uses thereof NGLY1, NRDC, MGAT3 PAOX 4007/4885TSHR 291/4885ZDHHC7 2199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.